AI in medical technology manufacturing: Balancing automation and human expertise

Editor's Note: This article originally appeared in the March 2026 print edition of Today's Medical Developments under the headline “Medtech discussions: Are you replacing your workforce with AI?”.

The rapid rise of artificial intelligence (AI) has reached every corner of medical technology – from device design and manufacturing to clinical decision support and hospital operations. AI isn’t a replacement for human experience, knowledge, and expertise. Implementing AI means combining human expertise with AI to create safer, faster, and more innovative medtech solutions.

AI’s promise in medtech is undeniable. Algorithms can analyze images in seconds, detecting early stages of cancer before they’re visible to the human eye. Companies such as GE HealthCare and Siemens Healthineers already use AI to accelerate MRI and CT image reconstruction, reducing scan times and improving throughput. AI can also analyze who’s at risk, for example based on family history, making treatment suggestions leading us closer to personalized medicine and at a lower cost. AI also assists with surgical planning and orthopedic implant choices.

Beyond the patient, AI can flag production defects invisible to the human eye, repeat high quality output with every production run, increase output with more shifts and predict supply shortages before they occur. Stryker employs machine-vision systems to inspect orthopedic implants with far greater consistency than manual inspection. These examples show AI can outperform humans in narrow, repetitive, data-heavy tasks.

While this progress is very positive, does it mean that we should replace people with intelligent machines? Consider how the entry of the computer to the workplace created a similar fear – taking over humans at work and home. We had to evolve; jobs changed, people remained.

Replacing people with AI is neither practical nor wise. Medtech is a highly regulated, high-stakes field where context, judgment, and accountability matter. An AI system may detect an anomaly on an ECG, but a clinician must decide whether it represents a life-threatening arrhythmia or harmless noise. Likewise, an automated production line can assemble a catheter, but engineers need to interpret failures, validate processes, and ensure compliance with FDA and EU MDR requirements. AI excels at pattern recognition; humans excel at responsibility.

Many organizations are upskilling current employees for success, and hiring for technical skill sets rather than full automation. Philips provides a good illustration. Its AI-enabled radiology tools pre-screen images and prioritize urgent cases, but radiologists make the final diagnosis. This has reduced turnaround times without compromising clinical authority. Similarly, Medtronic uses AI in its supply-chain planning to forecast demand for pacemakers and insulin pumps. Planners review the recommendations before orders are placed, blending algorithmic speed with human market insight.

For medtech manufacturers, the greatest opportunity lies in augmentation rather than substitution. AI helps design engineers run thousands of virtual prototypes overnight, yet creativity and clinical understanding remain human domains. Quality teams can use algorithms to detect trends across millions of data points, but deciding whether a signal requires a recall still demands ethical and regulatory judgment. Companies framing AI as a collaborator typically see higher adoption and less employee resistance.

If you can’t replace your workforce with AI, what makes sense? A mix of both. Let AI handle documentation, scheduling, and routine inspection. Train technicians to supervise robots and clinicians to interpret AI outputs. Establish clear validation, ethics, and cybersecurity frameworks Use algorithms to support design, diagnosis, and forecasting while keeping experts in charge.

AI will undoubtedly reshape medical technology and clinical practice, but it won’t replace the need for human ingenuity and compassion. Leading companies will use AI as a powerful new resource – one handling the heavy data lifting while people continue to provide the judgment, empathy, and accountability healthcare demands.

About the authors: CEO Florence Joffroy-Black is a long-time medtech M&A and marketing expert. She can be reached at florencejblack@medworldadvisors.com. Managing Director Dave Sheppard is a former medical OEM Fortune 500 executive and an experienced medtech M&A professional. He can be reached at davesheppard@medworldadvisors.com. Value = Strategic Fit + Timing® is a registered trademark of MedWorld Advisors.

MedWorld Advisors